labyrinthitis: Inflammation of the inner ear. The cause is often not clear. It may be due to a virus, but it can also arise from bacterial infection, head injury, extreme stress, an allergy, or as a reaction to medication. [ https://en.wikipedia.org/wiki/Labyrinthitis NCIT:C128369 ]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
117 |
4. Check minimum number of eventsNone |
117 |
5. Include endpointsNone |
117 |
6. Filter based on genotype QC (FinnGen only) |
117 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H83
- Name in latin
- Labyrinthitis
Similar endpoints
↥List of similar endpoints to
Labyrinthitis
based on the number of shared cases.
Similar with more cases:
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1255 | 675 | 574 |
| Only index persons | 913 | 513 | 400 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 36.37 | 39.34 | 32.62 |
| Only index persons | 37.48 | 39.64 | 34.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 117 | 80 | 37 |
| Unadjusted period prevalence (%) | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | 43.02 | 38.94 | 51.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 108
- Matched controls
- 1080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H83.0
ICD-10 Finland
Labyrinthitis
+∞
89.4
73
*
38403
ICD-8 Finland
Other inflammatory diseases of ear, Labyrinthitis
+∞
34.2
31
*
R42
ICD-10 Finland
Dizziness and giddiness
4.7
10.6
42
129
H81.3
ICD-10 Finland
Other peripheral vertigo
97.3
8.5
9
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
6.2
7.2
19
36
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
9.7
6.8
13
15
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
28.5
6.3
8
*
H81.2
ICD-10 Finland
Vestibular neuronitis
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
49
272
2.38
4.82
4.5
2.8
u/l
34.0
28.3
1.08
49
256
(3007853) Bacteria identified in Skin by Aerobe culture
24
95
2.92
4.66
2.8
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
308
2.16
3.95
3.3
2.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
55
3.21
3.91
1.8
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
52
324
2.09
3.65
3.5
3.4
e6/l
243.4
64.6
0.39
39
235
(3030467) Casts [#/volume] in Urine by Automated count
42
249
2.07
3.31
3.3
2.8
e6/l
0.6
0.3
0.40
34
194
(3012544) pH of Venous blood
20
88
2.54
3.15
7.5
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
45
279
2.00
3.11
7.1
4.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
16
5.28
3.11
1.6
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
24
119
2.28
2.92
3.2
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
44
276
1.95
2.91
3.4
2.9
e6/l
32.5
57.2
0.43
37
219
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
181
2.06
2.81
4.0
1.6
mg/l
1.3
1.1
0.25
26
142
(3013650) Neutrophils [#/volume] in Blood by Automated count
72
536
1.89
2.79
10.3
8.7
e9/l
4.2
4.0
0.28
63
465
(3013115) Eosinophils [#/volume] in Blood
64
459
1.87
2.79
9.0
5.4
e9/l
0.2
0.2
0.66
58
409
(3019198) Lymphocytes [#/volume] in Blood
64
459
1.87
2.79
8.3
5.0
e9/l
1.9
1.9
0.02
59
413
(3006315) Basophils [#/volume] in Blood
62
443
1.85
2.71
8.4
5.1
e9/l
0.0
0.0
0.65
54
388
(3035350) Ketones [Presence] in Urine by Test strip
62
447
1.82
2.60
3.4
3.7
estimate
0.0
0.0
0.00
12
87
(3021601) Nitrite [Presence] in Urine by Test strip
62
447
1.82
2.60
4.8
5.0
estimate
0.0
0.0
0.00
12
87
(36304419) Bacteria [Presence] in Urine
39
245
1.89
2.52
3.1
2.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
213
1.92
2.48
2.5
3.8
kg/l
1.0
1.0
—
6
27
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
12
5.20
2.43
1.7
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
12
5.20
2.43
1.2
2.6
mg/l
10.8
9.4
—
6
12
(3001604) Monocytes [#/volume] in Blood
61
444
1.78
2.42
8.5
5.0
e9/l
0.6
0.6
0.03
53
385
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
121
2.12
2.42
2.4
2.7
e6/l
3.4
3.6
0.05
14
70
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
17
4.31
2.40
2.7
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
17
4.31
2.40
2.1
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
8
6.47
2.39
2.0
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
8
6.47
2.39
2.6
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
8
6.47
2.39
2.0
2.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
9
5.74
2.23
1.0
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
9
5.74
2.23
1.2
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
17
82
2.26
2.20
2.3
2.3
nmol/l
487.9
367.2
0.69
17
75
(3023368) Bacteria identified in Blood by Culture
35
221
1.83
2.19
6.1
3.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
19
3.85
2.18
2.6
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
61
454
1.72
2.17
3.5
3.7
estimate
0.0
0.0
0.00
12
85
(3018418) pH of Serum or Plasma
40
266
1.77
2.11
4.3
3.6
ph
7.3
7.4
—
6
51
(3027273) Bicarbonate [Moles/volume] in Venous blood
12
50
2.56
2.10
7.6
3.1
mmol/l
24.2
24.8
0.21
12
50
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
20
3.65
2.09
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
83
679
1.77
2.04
10.3
7.0
u/l
82.3
76.4
0.44
76
630
(40758558) Short blood count panel - Blood
37
245
1.75
1.96
9.2
6.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
17
3.66
1.86
1.2
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
103
2.01
1.85
1.7
1.3
—
—
—
0
0
(4034850)
7
23
3.17
1.83
5.7
10.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
82
681
1.68
1.78
5.4
3.7
mm/h
14.4
11.0
1.06
77
614
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
50
369
1.62
1.74
3.6
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
54
407
1.61
1.72
11.8
8.3
e9/l
0.0
0.0
0.00
41
328
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
72
582
1.62
1.71
4.4
2.8
u/l
48.7
43.2
0.26
67
550
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
32
211
1.71
1.70
3.5
2.2
—
—
—
0
0
(3015736) pH of Urine
48
353
1.61
1.68
3.1
3.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
14
3.68
1.63
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
71
2.10
1.62
6.6
5.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
13
64
2.16
1.61
5.8
2.5
ng/l
91.4
72.0
0.36
13
57
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.10
1.60
2.2
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
20
117
1.86
1.57
1.5
1.3
titre
400.0
591.1
—
5
27
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
133
1.81
1.56
2.7
2.6
e6/l
2.5
0.9
1.27
14
81
(3032080) INR in Blood by Coagulation assay
46
340
1.58
1.56
11.6
7.2
inr
1.0
1.2
3.41
13
112
(3037467) Urinalysis macro (dipstick) panel - Urine
77
641
1.59
1.55
4.7
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
200
1.67
1.53
2.7
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
51
389
1.55
1.50
2.6
2.1
nmol/l
77.3
75.4
0.15
42
336
(3008037) Lactate [Moles/volume] in Venous blood
6
22
2.82
1.45
9.2
3.5
mmol/l
1.5
1.4
—
6
22
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
16
3.22
1.45
1.8
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
95
840
1.70
1.41
4.2
4.3
mmol/l
5.7
5.9
0.48
87
753
(3003396) Base excess in Arterial blood by calculation
17
98
1.86
1.40
3.7
6.1
mmol/l
0.6
1.3
0.67
11
75
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
100
898
1.78
1.38
24.1
13.0
mg/l
25.3
22.4
0.36
87
693
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
47
2.23
1.38
9.8
3.6
%
52.3
48.4
—
10
47
(3026008) Bacteria identified in Urine by Culture
39
289
1.52
1.27
3.1
3.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
19
2.70
1.23
6.2
1.1
g/l
0.0
0.0
—
5
19
(3044640) Blood type and Crossmatch panel - Blood
40
302
1.49
1.19
3.4
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
213
1.55
1.18
4.7
5.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
30
2.42
1.14
1.4
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
59
1.95
1.11
4.1
3.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
5
21
2.44
1.10
1.6
1.2
mg/l
310.2
394.5
—
5
21
(3038515) Glucose [Moles/volume] in Venous blood
5
21
2.44
1.10
10.8
3.6
mmol/l
10.9
7.5
—
5
21
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
131
1.64
1.09
3.3
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
45
2.08
1.08
2.3
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
45
2.08
1.08
2.3
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
607
1.43
1.07
3.7
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
83
1.78
1.07
3.6
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
83
1.78
1.07
3.2
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
47
1.99
1.05
4.9
2.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
22
2.33
1.04
9.2
2.8
mmol/l
22.2
25.2
—
5
16
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
22
2.33
1.04
1.6
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
61
1.89
1.02
3.3
3.8
pmol/l
4.5
4.5
0.03
11
54
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
97
885
1.56
1.00
5.1
4.6
mmol/l
3.0
2.7
2.61
88
806
(3045414) Leukocytes [Presence] in Urine
7
37
1.95
0.96
1.1
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
55
1.89
0.95
1.7
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
27
2.29
0.95
2.3
1.3
g/l
0.2
0.2
—
6
27
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
27
2.29
0.95
5.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
92
834
1.48
0.94
23.9
13.2
%
38.3
39.7
0.72
71
623
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
28
2.20
0.93
2.7
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
28
2.20
0.93
2.3
1.3
g/l
1.2
1.2
—
6
28
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
31
1.98
0.85
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
34
265
1.40
0.83
3.6
3.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
32
1.92
0.83
1.5
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
32
1.92
0.83
2.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
32
1.92
0.83
1.5
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
32
1.92
0.83
1.3
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
58
1.79
0.82
1.8
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
33
1.86
0.80
15.5
3.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
27
0.00
0.78
0.0
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
34
1.80
0.77
1.7
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
196
1.42
0.76
2.1
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
91
836
1.40
0.75
18.5
12.0
ml/min/173m2
81.5
82.3
0.12
79
668
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
39
1.84
0.74
2.1
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
93
1.57
0.73
2.0
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
16
110
1.53
0.73
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
190
0.64
0.73
1.5
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
26
1.96
0.71
6.4
5.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
27
1.89
0.69
2.4
2.1
—
—
—
0
0
(3036489) Thrombin time
5
29
1.76
0.64
16.2
1.7
s
31.2
20.6
—
5
24
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
30
1.70
0.62
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
30
1.70
0.62
1.6
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
51
1.61
0.62
5.0
2.2
%
0.9
1.5
—
8
51
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
13
89
1.52
0.61
3.0
2.0
u/l
34.3
28.1
0.24
13
72
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.7
—
50.6
—
0
21
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
214
1.34
0.60
1.7
1.4
g/l
2.6
2.3
0.56
19
122
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
87
805
1.31
0.59
5.7
5.5
mmol/mol
40.1
39.6
0.20
82
738
(3029937) Albumin [Presence] in Urine by Test strip
32
262
1.30
0.57
3.7
3.8
estimate
0.0
0.0
0.00
13
85
(40761511) CBC panel - Blood by Automated count
101
957
1.40
0.56
20.7
12.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
38
1.61
0.55
2.0
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
6
97
0.60
0.55
3.2
4.8
%
31.7
32.5
—
6
57
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
50
436
1.26
0.54
5.6
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
40
1.53
0.52
2.3
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
27
219
1.30
0.51
2.0
3.0
mg/l
2950.4
57.0
0.47
14
136
(3000330) Specific gravity of Urine by Test strip
7
46
1.55
0.49
6.3
3.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
29
240
1.28
0.48
3.2
3.8
mg/mmol
10.9
7.2
0.22
16
147
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
41
356
1.23
0.45
2.0
1.8
pmol/l
103.2
97.3
0.19
20
175
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
87
1.42
0.44
2.0
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
123
1.35
0.43
1.4
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
41
359
1.22
0.41
2.2
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.0
—
1.2
—
0
8
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
9.9
—
0
10
(3002256) Pathology report gross observation
14
107
1.35
0.39
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
36
1.41
0.38
1.0
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
29
247
1.23
0.38
2.0
2.8
mmol/l
8.4
7.7
0.25
23
207
(3044889) 12 lead EKG panel
67
619
1.19
0.38
3.5
3.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
80
0.61
0.36
2.2
2.2
—
—
—
0
0
(3019225) pH of Specimen
5
80
0.61
0.36
8.4
4.9
—
—
—
0
0
(3020891) Body temperature
6
41
1.49
0.36
4.5
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
42
1.45
0.36
5.5
7.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
43
1.42
0.35
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
37
329
1.18
0.31
6.5
3.8
ng/l
27.8
36.3
0.31
25
228
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
56
1.27
0.30
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
56
1.27
0.30
1.1
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
168
1.23
0.29
1.2
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
77
1.33
0.27
3.2
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
238
1.17
0.25
1.4
1.2
u/ml
0.7
1.1
—
7
65
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
144
1.21
0.23
3.8
4.0
%
19.5
24.5
—
9
64
(1761868) Lipid panel - Serum or Plasma
36
327
1.15
0.23
3.1
2.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
40
1.26
0.22
1.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
41
1.23
0.22
1.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
41
1.23
0.22
1.0
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
8
101
0.78
0.22
2.9
2.5
%
2.1
1.7
—
8
87
(3027008) Opiates [Presence] in Urine
5
42
1.20
0.22
1.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
42
1.20
0.22
1.0
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
11
0.00
0.21
0.0
1.6
—
88.6
—
0
11
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.9
—
0
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
13
0.00
0.21
0.0
1.5
—
32.1
—
0
13
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
119
1.20
0.18
1.4
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
196
1.15
0.18
1.5
2.0
—
—
—
0
0
(4035726)
10
82
1.24
0.17
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
66
0.75
0.17
1.2
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
5
69
0.71
0.17
2.4
2.8
e9/l
72.5
72.9
—
5
57
(40761536) Microorganisms panel - Urine sediment
6
76
0.78
0.16
6.7
3.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
75
0.79
0.16
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
79
1.15
0.15
1.0
1.1
—
—
—
0
0
(3013512) EKG study
27
252
1.09
0.10
7.0
3.7
—
—
—
0
0
(4010399)
6
58
1.04
0.08
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
60
0.83
0.08
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
74
1.09
0.07
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
112
0.88
0.07
8.8
7.2
—
—
—
0
0
(3000492) Spirometry study
8
78
1.03
0.07
1.6
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
18
170
1.07
0.04
2.7
2.4
mmol/l
2.4
2.5
0.24
13
149
(3022145) Colonoscopy Study observation
11
101
1.10
0.04
1.6
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
31
320
0.96
0.03
3.4
3.0
mmol/l
2.3
2.4
0.56
26
274
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
103
1.08
0.02
1.9
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
124
0.96
0.00
2.3
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
26
257
1.02
0.00
1.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
16
161
0.99
0.00
1.7
1.2
iu/ml
25.0
42.5
—
5
44
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
82
0.97
0.00
1.4
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
50
1.00
0.00
3.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
4.0
—
0
7
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
13.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
12.9
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
26.3
—
0
9
(21494434) Karyotype in Bone marrow
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
2.8
—
0
9
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.0
—
0.6
—
0
8
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
30.0
—
1592.3
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
3.5
—
13.9
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
140
1.00
0.00
2.3
2.2
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
20.5
—
870.8
—
0
6
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
8
0.00
0.00
0.0
1.0
—
10.4
—
0
8
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_LABYRINTHITIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_LABYRINTHITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_LABYRINTHITIS – Labyrinthitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data